Cambia lingua:
REACh compliance

Registration, Evaluation and Authorisation of Chemicals.

REACH stands for Registration, Evaluation, Authorization and Restriction of Chemicals and represents the European Commission Regulation on the management of chemicals, including their safe use. REACH was created with the aim of improving the protection of human environment health through a better knowledge of the intrinsic properties of chemical substances and involves manufacturers, importers and downstream users of chemicals. In particular, manufacturers and importers have to comply with the requirement of "registration", providing ECHA (European Chemical Agency) with a range of information on the physico-chemical, toxicological and ecotoxicological properties of substances .

Our main services

  • Company auditing and verification of regulatory compliance, of obligations and requirements (roadmap).
  • Pre-registration, inquiry and registration of substances, intermediates, PPORD.
  • Support for the management of SIEFs, for access to data and evaluation of the letters of access. Reassessment and update of the registration dossier.
  • Testing strategies in order to identify the substances for registration/inquiry purposes.
  • Support for the request of an application and for the renewal of an authorization.
  • Strategies for the elimination of highly dangerous substances and substitution plans.
  • Verification of the compliance with restrictions on uses.
  • Testing strategies in order to determine the SVHC and restricted substances in articles.
  • Compilation of safety data sheets (MSDSs) and extended safety data sheets (E-SDSs) for substances and mixtures.
  • Elaboration of exposure scenarios (CSR-ES) of DU and DU-CSR.
  • Integration into the Company Management System of the requirements requested by the REACH Regulation.
  • Training to Companies about REACH and CLP inspections and support during and after verification.
  • Testing strategies and toxicological evaluations (hazard, exposure and/or risk assessment) both in vivo/in vitro and using specific tools (eg. QSAR models, read-across techniques, in silico models for the estimation of exposure)

For further information on our consultancy contact us
© NORMACHEM Srl via Roma 14, 35014 - Fontaniva (Padova), Italia - Capitale Sociale 50.000 euro - REA PD 389472 - P.Iva: 04434700284 - Privacy Policy - Site Credits